Shionogi & Co. Ltd. has filed for the first Japanese approval of a digital therapeutic app, for pediatric attention deficit hyperactivity disorder (ADHD), potentially providing a new treatment option beyond medications in the country's growing market for the disorder.
First Digital Therapeutic App Filed For Approval In Expanding Japan ADHD Market
A pioneering approval filing for a therapeutic app by Shionogi is set to herald expansion of ADHD therapies beyond the pill in Japan, along with growth in the pediatric segment for the disorder.